Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer
Clinical trial NCT05032313 · COMPLETED
Trial details
- NCT number
- NCT05032313
- Sponsor
- Becton, Dickinson and Company
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-26
- Primary completion
- 2023-12-29
- Enrollment
- 371
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.